EUVIMEDEUVIMED entdecken
Crossref

Spink1 promotes the survival of Kras-mutant pancreatic acinar cells

Hidehiro Hayashi, Shin Hamada, Ryotaro Matsumoto, Tetsuya Takikawa, Yan Xu, Ren Jie, Hitomi Nakasuji, Toshiaki Abe, Kazuhiro Kikuta, Hozumi Motohashi, Masaki Ohmuraya, Atsushi Masamune

Pancreatology · 2026

DOI: 10.1016/j.pan.2026.03.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2026. Verfasst von Hidehiro Hayashi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. Hauptthemen laut MEDLINE: Acinar Cells, Trypsin Inhibitor, Kazal Pancreatic, Proto-Oncogene Proteins p21(ras), Pancreas. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Tohoku University, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pancreatic cancer remains one of the most intractable malignancies due to its strong therapeutic resistance and the difficulty of early detection. Previous studies have suggested that pancreatic inflammation can promote carcinogenesis. In contrast, the regulatory mechanisms controlling trypsin activity are closely associated with susceptibility to pancreatitis. Genetic variants that lead to sustained trypsin activity-thereby promoting protease activation-have been identified in hereditary pancreatitis. Serine protease inhibitor Kazal type 1 (SPINK1) functions as an endogenous inhibitor of trypsin activity. Deletion of Spink1 in mice causes severe pancreatic atrophy and early postnatal death. In addition to its role in pancreatitis, SPINK1 has been reported to exert cancer-promoting effects in several tumor types by supporting cell survival. METHODS: In the present study, we investigated whether pancreas-specific deletion of Spink1 affects inflammation and fibrosis after caerulein-induced pancreatitis. We also investigated whether pancreas-specific deletion of Spink1 affects Kras-mutant driven carcinogenesis in mice. RESULTS: Loss of Spink1 in the pancreas induced histological changes consistent with chronic pancreatitis and was accompanied by muscle atrophy. Moreover, the combination of Spink1 deletion and mutant Kras expression resulted in early lethality due to severe pancreatic atrophy. Heterozygous loss of Spink1 also attenuated the development of pancreatic intraepithelial neoplasia (PanIN), a precancerous lesion induced by mutant Kras. CONCLUSIONS: These findings demonstrate that SPINK1 supports the early stages of pancreatic carcinogenesis. Targeting SPINK1 may represent a novel preventive strategy to eliminate Kras mutant acinar cells and suppress the initiation of pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinar CellsTrypsin Inhibitor, Kazal PancreaticProto-Oncogene Proteins p21(ras)PancreasAnimalsMicePancreatic NeoplasmsCell SurvivalMutationCeruletideMalePancreatitisMice, KnockoutGlycoproteinsProstatic Secretory Proteins

Stichwörter der Autor:innen

Acinar cell deathKrasPancreatic cancerPancreatitisSpink1

Substanzen

Spink1 protein, mouseTrypsin Inhibitor, Kazal PancreaticProto-Oncogene Proteins p21(ras)CeruletideHras protein, mouseGlycoproteinsProstatic Secretory Proteins

Autor:innen und Institutionen

  • Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
  • Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. Electronic address: shin.hamada.b6@tohoku.ac.jp.
  • Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
  • Department of Genetics, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Tohoku University
  • Wellcome Trust

Zitieren

APA

Hayashi, H., Hamada, S., Matsumoto, R., Takikawa, T., Xu, Y., Jie, R., Nakasuji, H., Abe, T., Kikuta, K., Motohashi, H., Ohmuraya, M., & Masamune, A. (2026). Spink1 promotes the survival of Kras-mutant pancreatic acinar cells. Pancreatology. https://doi.org/10.1016/j.pan.2026.03.014

Vancouver

Hayashi H, Hamada S, Matsumoto R, Takikawa T, Xu Y, Jie R, et al. Spink1 promotes the survival of Kras-mutant pancreatic acinar cells. Pancreatology. 2026. doi:10.1016/j.pan.2026.03.014

BibTeX
@article{Hayashi2026,
  author = {Hayashi, Hidehiro and Hamada, Shin and Matsumoto, Ryotaro and Takikawa, Tetsuya and Xu, Yan and Jie, Ren and Nakasuji, Hitomi and Abe, Toshiaki and Kikuta, Kazuhiro and Motohashi, Hozumi and Ohmuraya, Masaki and Masamune, Atsushi},
  title = {Spink1 promotes the survival of Kras-mutant pancreatic acinar cells},
  journal = {Pancreatology},
  year = {2026},
  doi = {10.1016/j.pan.2026.03.014}
}
Kostenlos starten →